Shannon Thyme Klinger
Chief Legal Officer & Corporate SecretaryMs. Shannon Thyme Klinger, J.D., is Vice Chair of Association of Corporate Counsel from October 2025. Ms. Klinger serves as Independent Board Member at Rejuveron Life Sciences AG. She is Member of Strategic Advisory Board of PERSUIT from February 2025. Ms. Shannon Thyme Klinger serves as Chief Legal Officer and Corporate Secretary at Valera LLC. She served as Director of Rafael Holdings, Inc. since June 2021 until May 24, 2022. Ms. Klinger serves as Chief Legal Officer & Corporate Secretary at Moderna, Inc. since June 1, 2021. Ms. Klinger served as Chief Legal Officer at Novartis AG since July 2020 until March 15, 2021 and also had been Group General Counsel since June 1, 2018 until July 2020. She served as the Chief Ethics, Risk and Compliance Officer at Novartis AG since April 1, 2018 until June 1, 2018 and served as its Chief Ethics & Compliance Officer and Head of Litigation since May 1, 2016 until April 1, 2018. Ms. Klinger served as Global Head of Litigation at Novartis AG. Ms. Klinger served as Head of Legal and General Counsel at Sandoz International GmbH from 2012 to 2016. She joined Novartis in 2011 and later became the Global Head of Legal and General Counsel for Sandoz International GmbH. She served as a Partner at Mayer Brown LLP from 2010 to 2011. Before joining Mayer Brown, Ms. Klinger served as Senior Vice President and General Counsel at Solvay Pharmaceuticals Inc. from 2008 to 2010. Ms. Klinger served as Vice President of Legal & Intellectual Property and General Counsel of North America at Sandoz Inc. since 2011 until 2012. She served as Vice President of Marketing Compliance and Associate Counsel at Teva Branded Pharmaceutical Products R&D, Inc. (formerly, Barr Pharmaceuticals Inc.). She joined Barr Pharmaceuticals legal department in 2005 and was responsible for all Medicare/Medicaid compliance activities. She served as Associate of Alston & Bird LLP, Atlanta, GA and Washington, DC, USA from 1996 to 2003 and served as its Partner from 2004 to 2005. She served as General Counsel North Amerika Sandoz Inc. from 2011 to 2012. She served as Vice-President of Marketing Compliance and Associate Counsel at Barr Laboratories/Duramed Pharmaceuticals, Washington, DC, USA from 2005 to 2007. She served as Director of SIX Group AG since May 20, 2016 until November 2020. She is a frequent author and lecturer on topics related to Food & Drug Law, government enforcement and antitrust enforcement. She has global pharmaceutical experience across a wide range of strategically-important areas including legal, compliance, IP, business development, licensing, mergers and acquisitions, public/government affairs, communications, risk management, quality and regulatory affairs. She serves as a Board member, SwissHoldings, the Swiss federation of industrial and service groups, Switzerland. She holds Bar memberships: State of Georgia, District of Columbia, US. Ms. Klinger also led the development and implementation of a Foreign Corrupt Practices Act compliance program in more than 25 EU and non-EU countries, including Croatia, Poland, Hungary, Russia, Ukraine, Germany and the Czech Republic. Ms. Klinger holds Bachelors in Psychology from University of Notre Dame (USA) and a Juris Doctor with Honours from University of North Carolina at Chapel Hill (USA), School of Law.
Positions
- Company NameModerna, Inc.Stock CodeMRNAPositionChief Legal Officer & Corporate SecretaryColleagues
- SBStéphane BancelCEO & Director
- NBNoubar B. AfeyanCo-Founder, Independent Non Executive Chairman & Member of Technology Advisory Board
- SHStephen HogePresident
- JMJames M. MockChief Financial Officer
- JAJuan AndresChief Operating Officer
- DEDarin EdwardsExecutive Director
- JWJack W. SzostakChairman of Scientific Advisory Board
- FNFrancois NaderIndependent Non Executive Director
